Imaxio Announces the First Human Clinical Trial Using IMX313 in Tuberculosis

News   Sep 04, 2013

 
Imaxio Announces the First Human Clinical Trial Using IMX313 in Tuberculosis
 
 
 

RELATED ARTICLES

Putting the Brain at the Center of Anesthesiology

News

Emery N. Brown explains how statistics and neuroscience improve anesthesiology at the American Association for the Advancement of Science's annual meeting.

READ MORE

Computational Model Underlines Need for Personalised Approach to Sepsis

News

A computational model of the human immune system has enabled researchers to explore the challenges of tackling sepsis.

READ MORE

Allergies and Asthma Possibly Linked to Female Hormones

News

Fluctuations in female sex hormones could play a role in the development of allergies and asthma, a major review of evidence suggests. Analysis of studies involving more than 500,000 women highlights a link between asthma symptoms and key life changes such as puberty and menopause. Further investigation could help explain why asthma is more common in boys than girls in childhood, but more common in teenage girls and women following puberty.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE